Steven Humphreys, MD
Orthopaedic Surgery of the Spine · Soldotna, AKNPI 1144225798
Payments from drug & device makers
What this record shows
This record is dominated by royalties or licence payments: $183,897 of the $198,796 with a category attached, or 92.5%. 11 manufacturers reported payments, led by Spineart SA at 59.4% of the total.
Across 110 payments — averaging $1807.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Spineart SA$118K
- Medical Investment Advisors LLC$66K
- Stryker$4K
- Globus Medical$4K
- Medtronic$3K
- Aesculap Implant Systems, LLC$1K
- plus $3K from 5 others
What the payments were for
- Royalty or licence$183,89793%
- Consulting fees$5000%
- Travel & lodging$11,4976%
- Food & beverage$2,9021%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Spineart SA | 15 | $118,110 |
| Medical Investment Advisors LLC | 13 | $65,815 |
| Stryker | 22 | $4,134 |
| Globus Medical | 6 | $3,912 |
| Medtronic(2 entities) | 28 | $2,922 |
| Aesculap Implant Systems, LLC | 6 | $1,372 |
| Spineart USA Inc | 4 | $1,268 |
| Si-bone, Inc. | 4 | $851 |
| Abbott | 9 | $199 |
| Osteoremedies, LLC | 1 | $141 |
| Johnson & Johnson | 2 | $72 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CURE ACP - ANTERIOR CERVICAL PLATE$53,354
- PERLA C$47,478
- CURE ACPv2 - ANTERIOR CERVICAL PLATE$15,399
- ExcelsiusGPS Robotic Navigation System$3,881
- EVEREST SPINAL SYSTEM$2,152
- MAZOR X SYSTEM$2,005
- OPEL C - ANTERIOR CERVICAL PLATE$1,879
- TRITANIUM$1,297
- ACTIVL$1,248
- IFUSE IMPLANT SYSTEM$753
- CURE ACP$639
- Mazor X Stealth Edition$210
- ProLift$166
- Osteoboost Select 10cc$141
- N/A$137
- UNID_PASS$101
How this compares
Too few orthopaedic surgery of the spine providers in Alaskato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 12 | $505 |
| Gabapentin | 15 | $293 |
| Methocarbamol | 15 | $161 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 12 | $65 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery of the spine in Soldotna
- John AndreshakSoldotna$22K
- Samuel AdamsSoldotna$17K
- Stewart KerrFairbanks$51K
- Iain ElliottAnchorage$30K
- James EuleAnchorage$17K
- Derrick FogeAnchorage$7K
- Gene FalkowskiAnchorage$5K
- Upshur SpencerAnchorage$4K
- Brent AdcoxHomer$4K
- Mark FlanumAnchorage$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.